BR0104359A - Decursinol ou seus derivados a partir de agenteanalgésico - Google Patents

Decursinol ou seus derivados a partir de agenteanalgésico

Info

Publication number
BR0104359A
BR0104359A BR0104359-5A BR0104359A BR0104359A BR 0104359 A BR0104359 A BR 0104359A BR 0104359 A BR0104359 A BR 0104359A BR 0104359 A BR0104359 A BR 0104359A
Authority
BR
Brazil
Prior art keywords
decursinol
derivatives
analgesic agent
enoyl
methyl
Prior art date
Application number
BR0104359-5A
Other languages
English (en)
Inventor
Hi Yung Kim
Keun-Dong Song
Won Hong Suh
Oh Sung Huh
Original Assignee
Scigenic Co Ltd
Getwellbio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scigenic Co Ltd, Getwellbio Inc filed Critical Scigenic Co Ltd
Publication of BR0104359A publication Critical patent/BR0104359A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

PATENTE DE INVENçãO: "DECURSINOL OU SEUSDERIVADOS A PARTIR DE AGENTE ANALGéSICO". A presenteinvenção refere-se a um composto para aliviar a dor de ummamífero, a partir do decursinol ou seus derivados, representadopela fórmula (I): onde R^ 1^ é hidrogênio, 3-metil-but-2-enoil ou2-metil-but-2-enoil; e R^ 2^ é hidrogênio ou hidróxi
BR0104359-5A 2000-01-24 2001-01-20 Decursinol ou seus derivados a partir de agenteanalgésico BR0104359A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20000003186 2000-01-24
KR10-2001-0000055A KR100397950B1 (ko) 2000-01-24 2001-01-02 데커시놀 또는 이의 유도체를 포함하는 진통제 조성물
PCT/KR2001/000103 WO2001052841A1 (en) 2000-01-24 2001-01-20 Decursinol or derivative thereof as analgesic agent

Publications (1)

Publication Number Publication Date
BR0104359A true BR0104359A (pt) 2001-11-27

Family

ID=26636822

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0104359-5A BR0104359A (pt) 2000-01-24 2001-01-20 Decursinol ou seus derivados a partir de agenteanalgésico

Country Status (9)

Country Link
US (1) US20020168436A1 (pt)
EP (1) EP1169034A4 (pt)
JP (1) JP3974397B2 (pt)
KR (1) KR100397950B1 (pt)
CN (1) CN1358093A (pt)
AU (1) AU756948B2 (pt)
BR (1) BR0104359A (pt)
EA (1) EA200101001A1 (pt)
WO (1) WO2001052841A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7026484B2 (en) * 2001-02-23 2006-04-11 Ligand Pharmaceuticals Incorporated Tricyclic androgen receptor modulator compounds and methods
KR100427704B1 (ko) * 2001-09-21 2004-04-30 주식회사 겟웰바이오 데커시놀을 포함하는 살리실산염 유도체-유발성 위점막손상의 예방 및 치료용 조성물
AU2002249639A1 (en) 2002-04-09 2003-10-27 Elcom Biotechnology, Co., Ltd. Pyranocoumarin derivatives
KR101072175B1 (ko) * 2004-06-22 2011-10-10 최백희 데커신 및/또는 데커시놀 안젤레이트, 또는 데커신및/또는 데커시놀 안젤레이트를 유효성분으로 하는당귀추출물을 포함하는 배뇨장애 치료제 및 부종 치료제조성물
KR100715206B1 (ko) * 2006-01-19 2007-05-04 박용진 참당귀로부터 데쿨시놀을 고수율로 제조하는 방법
KR20100009295A (ko) * 2008-07-18 2010-01-27 경북대학교 산학협력단 디커신 또는 디커시놀 안젤레이트를 함유한 ｖｅｇｆ에의해 유도된 신생혈관형성 관련 질환의 치료용 조성물
WO2011019867A2 (en) * 2009-08-12 2011-02-17 Melaleuca, Inc. Dietary supplements and methods for treating pain and inflammation
KR101585450B1 (ko) * 2011-01-27 2016-01-19 대우제약 주식회사 Ｄｅｃｕｒｓｉｎｏｌ 유도체를 포함하는 해열 및 진통제 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63255222A (ja) * 1987-04-14 1988-10-21 Nippon Petrochem Co Ltd クマリン類からなる虚血性心疾患治療用カルシウム拮坑剤
KR0176413B1 (ko) * 1993-09-07 1999-03-20 서정욱 항암제로서의 데커신
KR100187881B1 (ko) * 1996-07-25 1999-06-01 한승수 데커시놀 안젤레이트를 유효성분으로 하는 항암제
CA2347750C (en) * 1998-10-22 2008-01-08 Binex Co., Ltd. Pharmaceutical composition containing decursin
KR20000026683A (ko) * 1998-10-22 2000-05-15 정세영 신장독성 억제성분으로서 데커신을 포함하는의약조성물
KR20000026684A (ko) * 1998-10-22 2000-05-15 정세영 데커신을 유효성분으로 포함하는 암세포 분화유도제 조성물
CN1347316A (zh) * 1999-04-13 2002-05-01 科技基因有限公司 含羟基肉桂酸衍生物或其等同物的当归属植物提取物用于防止和治疗痴呆的化合物

Also Published As

Publication number Publication date
JP2003520231A (ja) 2003-07-02
KR100397950B1 (ko) 2003-09-19
CN1358093A (zh) 2002-07-10
AU756948B2 (en) 2003-01-30
EP1169034A1 (en) 2002-01-09
JP3974397B2 (ja) 2007-09-12
AU2891301A (en) 2001-07-31
WO2001052841A1 (en) 2001-07-26
US20020168436A1 (en) 2002-11-14
EP1169034A4 (en) 2009-03-18
EA200101001A1 (ru) 2002-02-28
KR20010086292A (ko) 2001-09-10

Similar Documents

Publication Publication Date Title
WO2001081310A8 (en) 1-aroyl-piperidinyl benzamidines
BRPI0114042B8 (pt) uso de composto bicíclico na fabricação de uma composição para alívio ou prevenção de constipação em um paciente humano constipado e limpeza de intestinos
DE60137966D1 (de) Anilinopyrimidin derivate als "jnk pathway inhibitoren", zusammensetzungen und damit verbundene behandlungsmethoden
BR0109165A (pt) Método de tratamento de pólipos colÈnicos
BR0113961A (pt) Método de analgesia
GB0225475D0 (en) Therapeutic agents
BR0114913A (pt) Inibidores de metaloproteinase de espiro-pirimidina-2,4,6-triona
BR0113389A (pt) Compostos que inibem a atividade do fator xa
BR0206372A (pt) Processo para sintetizar um composto
BR9910899A (pt) Compostos de ácido sulfÈnico ou sulfonilamino n-(hetero-aralquil)-azaeterocicliamida
BR0104359A (pt) Decursinol ou seus derivados a partir de agenteanalgésico
BR0214359A (pt) Método para tratar ou prevenir o mal de alzheimer e uma doença e para tratar um paciente que tem, ou para prevenir que um paciente adquira uma doença ou condição, para inibir a atividade de beta-secretase, a clivagem de um isotipo de proteìna de precursor amilóide e a produção de peptìdeo e de placa beta-amilóide e para produzir um complexo de beta-secretase, uso de um composto e, composição
SE9902267D0 (sv) New compounds
NO20060277L (no) Anvendelse av bisyklo [2.2.1] heptanderivater til fremstilling av nevrobeskyttende farmasoytiske sammensetninger
NO20014240L (no) C16-umettede FP-selektive prostaglandinanaloger
WO2001091796A8 (en) Methods, compounds and compositions for treating gout
SE0101082D0 (sv) Novel use
SE0004101D0 (sv) New use
BR0307521A (pt) Inibidores de adesão da célula mediada por alfa l beta2 integrina
BR0102940A (pt) Agente para o tratamento de doença de parkinson compreendendo um agente de melhora da função de astrócitos como ingrediente ativo
BR0110871A (pt) Derivados de sulfonamida
BR0112338A (pt) Composto, composição farmacêutica, e, uso de um composto
NO20054086L (no) Depigmenteringsmidler
DE60104589D1 (de) Therapeutisches Mittel zur Behandlung von Dermatitis
DE19780042D2 (de) Therapeutische Mittel, enthaltend organische Selenverbindungen gegen Asthma

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTA A 4A ANUIDADE.

B08H Application fees: decision cancelled [chapter 8.8 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1963 DE 19/08/2008 POR TER SIDO APRESENTADO PROTOCOLO DE ESCLARECIMENTO.

B07A Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 10 DA LPI

B15V Prolongation of time limit allowed

Free format text: RECONHECIDO O OBSTACULO ADMINISTRATIVO E DEVOLVIDO O PRAZO DE 17 DIAS PARA APRESENTACAO DE RECURSOCONTRA O INDEFERIMENTO, NOS TERMOS DO ARTIGO 221 PARAGRAFO 2O DA LPI E DA RESOLUCAO 116/04.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.